The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Shares of Inotiv (NOTV) were down $1.39, or 50%, to $1.42 near the close of trading after the Food and Drug Administration announced that it is ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of Brilinta for patients who have bleeding events or who need urgent surgery.

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.

Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha Tharimmune Inc. Mon, Mar 24, 2025, 8:00 AM 7 min read ...

The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.

TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...